-
'Role model' Stokes set to open for Adelaide Strikers
-
Farming experts tout 'conscious' food systems to fix agriculture woes
-
Palau urges 'unified' Pacific response to China missile test
-
George Lucas unveils art galaxy at his new LA museum
-
Grinding away: in remote Appalachia, old mills fuel US clean food dreams
-
Veteran Wallaby Slipper targets fifth World Cup after Brumbies deal
-
Sabalenka races into US Open third round
-
Sabalenka storms into US Open third round as Pegula, Medvedev advance
-
Chinese lucky loser stuns Jodar at US Open
-
Zverev looks to improve after first-round scare
-
US Open under the influence: content creators spark debate
-
Raiders to start Cousins over top NFL Draft pick Mendoza
-
NBA hammers Clippers over Leonard salary cap violations
-
Palantir chief says France's digital sovereignty push 'backfiring'
-
NBA strips five first-round draft picks from Clippers for Leonard salary cap violations
-
US energy firms dominate Venezuela deals worth billions
-
Kane brace helps Bayern win German Cup opener
-
Iran, US trade threats after escalation in fighting
-
Migrant plight, local anger divide Ceuta one month after influx
-
US jury deadlocks again in Lindsay Clancy's child murder trial
-
Outrage as Maltese tycoon acquitted of reporter's murder
-
Lake America? No way, Canadians say
-
Rare train of Pacific cyclones fueled by historic El Nino
-
Spain report flags Moroccan police failings in Ceuta migrant rush
-
Macron, King Charles hail UK-France ties after viewing Bayeux Tapestry
-
Tech bosses press G20 to build data centers, but split on risk
-
Fury hits out at 'coward' Joshua as 'Battle of Britain' talks go on
-
Dolly Parton to get new Hollywood star after vandalism
-
Maltese tycoon acquitted of masterminding reporter's murder
-
Trump 'happy' Prince Harry and Meghan have left US
-
George Clooney: a Hollywood icon and campaigner
-
Michelson shocks Nakashima in US Open clash of rising Americans
-
Europe, US closer than they look on tech rules, says EU tech chief
-
Another body recovered after ferry capsizes off northern Cyprus: official
-
Clooney honoured as Hollywood-light Venice Film Festival kicks off
-
Cupertino Chamber President Claudio Bono Invited to White House with GiveaRoof 3-Year Plan to End Homelessness
-
Third-ranked Pegula, Medvedev power into US Open third round
-
Trump floats renaming Strait of Hormuz as 'Trump Strait'
-
Davis-Woodhall a doubt for Ultimate Championship after car crash
-
Man City, Chelsea fuel record-breaking Premier League transfer window
-
Third-ranked Pegula powers into US Open third round
-
Balogun rejected Everton move over transfer 'treatment'
-
Uber says laying off 'about 10%' of workforce worldwide
-
Northampton seek 'happy medium' in bid to keep England star Pollock
-
US judge rejects bid to break up Google's ad business
-
US energy secretary in Venezuela to sign Trump's 'biggest' oil deal
-
Rupert Murdoch 'very happy' to be played by Guy Pearce in new film
-
Branagh takes on action role in Apple's Cold War comedy 'Mayday'
-
Wall Street stocks rise despite bond yields, oil rising
-
Lawson fills in again for injured Hadjar at Monza
DATATRAK ePRO/eCOA Solution Expands Decentralized Trial Platform
Device‑agnostic ePRO that is BYOD (bring your own device) with email/SMS reminders, patient portals, and unified reporting across EDC and eDiaries
AUSTIN, TX / ACCESS Newswire / March 10, 2026 / DATATRAK Powered by Fountayn, a unified eClinical and decentralized clinical trial (DCT) platform, today announced the availability of its enhanced electronic patient‑reported outcomes (ePRO) and eCOA solution, designed to help sponsors, CROs, and sites collect high‑quality patient data for hybrid and decentralized clinical trials. Built on DATATRAK's core eClinical platform, the ePRO module can be deployed as a standalone solution or tightly integrated with the DATATRAK EDC to support end‑to‑end digital trials.
DATATRAK ePRO is a device‑agnostic, true BYOD solution that allows patients to use their own smartphones, tablets, or computers, reducing study costs and barriers to participation. Study teams can configure eDiaries and electronic clinical outcome assessments (eCOA) using the same eCRF design toolkit they rely on for EDC casebooks, enabling faster start‑up and consistent design across all data capture tools.
"Our customers want ePRO that is flexible, affordable, and fully connected to their EDC - not another silo," said Alex Tabatabai, CEO, DATATRAK Powered by Fountayn. "With DATATRAK ePRO, sponsors and CROs can design and launch eDiaries and eCOA quickly, send automated email and SMS reminders, and analyze compliance alongside EDC casebook data, all within a single, unified platform."
Standalone ePRO or Fully Integrated with EDC
DATATRAK's ePRO solution is built on the same core platform as its EDC, RTSM, CTMS, eTMF, and eConsent tools. Customers can:
Use ePRO as a standalone product and integrate with third‑party EDC or clinical trial systems, or
Add ePRO as a native extension of the DATATRAK EDC to create a unified environment for data capture, randomization, and trial operations.
Sites can invite and enroll ePRO participants directly from the EDC, link patient‑reported outcome data to subject records, and trigger one‑time notifications from within the EDC workflow. This tight integration helps reduce manual reconciliation and improves data quality across the study lifecycle.
Patient Engagement Through Email/SMS and Secure Portal
To support patient engagement and compliance, DATATRAK ePRO includes:
Email and SMS notifications to remind participants when eDiary or eCOA entries are due
A patient portal with secure PIN sign‑in so participants can easily access their tasks and forms
Configurable one‑time notifications sent from the EDC to specific participants or cohorts
These communication tools help improve completion rates and provide sites with better visibility into participant status in real time.
Unified Reporting Across eDiaries and EDC
Flexible reporting tools span both EDC casebooks and eDiaries, enabling study teams to build compliance and performance reports that incorporate patient‑reported outcomes alongside other clinical data. This unified view supports better decision‑making, early signal detection, and streamlined preparation for data reviews and regulatory inspections.
With databases hosted in key regions including the United States, Japan, and Europe -and options for additional local data hosting-DATATRAK Powered by Fountayn supports global studies while aligning with regional data privacy and security requirements.
About DATATRAK
Datatrak is transforming healthcare and life sciences through technological innovations from providing the first EDC technology to offering the first true eSource solution that seamlessly integrates all aspects of clinical trial data management including EDC, RTSM, RBM, eTMF, CTMS, ePRO, eConsent, Endpoint Adjudication, Imaging Data, Safety, Inventory Management, and Enterprise Management of Automated Alerts, Workflows, Documents, Timelines, and Global Oversight. No other company has been innovating in healthcare and life sciences as long as Datatrak. For over thirty years clinical trial professionals have trusted Datatrak for reliable and secure technology solutions. Datatrak complies with the highest Quality Assurance standards that are 21 CFR Part 11, GDPR, GCP, HIPAA, and CDISC compliant that are fully validated by our experienced team of software quality engineers. Datatrak's cloud-based platform is trusted in 83 countries, 6 continents, for over 10,000 clinical trials. Datatrak is based in Austin, Texas and has team members and data hosting infrastructure in its key service regions of the United States, Europe, and Japan. For more information, visit www.datatrak.com or www.fountayn.com.
Contact:
Sales Department
[email protected]
SOURCE: Datatrak International
View the original press release on ACCESS Newswire
O.Johnson--AMWN